Investigator Brochure Template

Easily Editable & Printable.

Investigator brochure template. Sample Investigator's Brochure Template. This 21-page Investigator’s Brochure Template is intended to assist you in the process of drafting an Investigator’s brochure for Devices, based on ICH Topic E 6 (R1) “Guideline for Good Clinical Practice”. Investigator´s Brochure for ATMP Introduction: UCL JRO IB Template V1.0 14th February 2019 CONFIDENTIAL Page 4 of 13 1.

Investigator Brochure (IB) Template. Investigator’s Brochure Content, Design, Amendments, Filing & Distribution Version 1.0 dated 9 November 2017 Page 3 of 5 The specific content of an IB will vary depending on whether the subject of investigation is a medicinal product or device. In the absence of detailed guidance or a template for the content of the Investigator´s brochure (IB) for advanced therapeutic medicinal product (ATMP) development quality, this document has been created as an authoring guide Never underestimate the ability of excellent brochures.

TMP-QA-6 V2 (1-4-17) Investigator Brochure template. Instantly Download Investigator Tri-Fold Brochure Template, Sample & Example in Microsoft Word (DOC), Adobe Photoshop (PSD), Adobe InDesign (INDD & IDML), Apple Pages, Microsoft Publisher, Adobe Illustrator (AI) Format. 5.1 Summary of the risk analysis . ABT-267, ABT 333, ABT-450 and Ritonavir :

For suggested format of Investigator’s Brochure refer to Guidance for Industry: A protocol synopsis in the format of the Protocol Safety and Efficacy Assessment Template - Clinical Trial Application (PSEAT-CTA) should be submitted. The Investigator's Brochure containing all information regarding the product should be prepared in accordance with the Health Canada / ICH Guidance Document E6:. Investigator’s Brochure Edition 11 Confidential 1 INVESTIGATOR’S BROCHURE Orteronel (TAK-700) MILLENNIUM PHARMACEUTICALS, INC.

The Investigator’s Brochure (IB) is a multidisciplinary document that summarises the main elements of an entire development programme to date. The purpose of the investigator’s brochure (IB) is to provide the principal investigator(s) with sufficient safety or performance data from pre-clinical investigation(s) and/or clinical investigation(s) to justify human exposure to the investigational device specified in the clinical investigational protocol. This template has been devised to be consistent with I SO 141555-2011 GCP for medical d evices . Available in (US) 8.5x11, (A4) 8.27x11.69 inches + Bleed.

QH GCP SOP 4: Bedaquiline (TMC207) Janssen Research & Development : 40 Landsdowne Street Cambridge, MA 02139 USA Issue Date: Consolidated Guidance (PDF - 262KB).

For guidance on the content and Investigator's Brochure (IB) Table. SUMMARY This section should contain a brief (maximum of two pages) summary highlighting the significant points included in this document. Integrated Addendum to ICH E6(R1) Guidance for Industry .

A description summary of the results of the risk analysis carried out on the investig ative device, Food and Drug Administration Download Investigator Brochure for Free FormTemplate offers you hundreds of resume templates that you can choose the one that suits your work experience and sense of design. The IB may cover multiple research projects sponsored by the same research sponsor and using the same Medicinal Product (MP) in the same formulation.

Department of Health and Human Services . Blank Investigator's Brochure Template free download and preview, download free printable template samples in PDF, Word and Excel formats E6 Good Clinical Practice: The Table of Contents for the IB template is shown in Guideline Attachment 1.

RISK MANAGEM ENT . Page 5 of 7. Although the IB also serves other purposes, it is primarily written to enable investigators conducting clinical studies to assess the risks and benefits associated with an investigational product. Edition 10, dated 04 February 2014 Disclosure Statement

An IB should only be written when no Summary of Product Characteristics (SmPC Page 6 of 6 . The Investigator’s Brochure is given to clinicians, investigators, and other healthcare professionals involved in the conduct of clinical trials (for instance, the clinical trial coordinators and study nurses).